Found: 6
Select item for more details and to access through your institution.
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 672, p. 1, doi. 10.1126/scitranslmed.abq7019
- By:
- Publication type:
- Article
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4753, doi. 10.3390/cancers13194753
- By:
- Publication type:
- Article
The E3 ubiquitin ligase Itch inhibits p38a signaling and skin inflammation through the ubiquitylation of Tab1.
- Published in:
- Science Signaling, 2015, v. 8, n. 365, p. 1, doi. 10.1126/scisignal.2005903
- By:
- Publication type:
- Article
Toll-like receptors and NOD-like receptors in pulmonary antibacterial immunity.
- Published in:
- Innate Immunity, 2010, v. 16, n. 3, p. 201, doi. 10.1177/1753425910366058
- By:
- Publication type:
- Article
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adi4191
- By:
- Publication type:
- Article
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article